Published on
March 28, 2022
- 05:00 GMT
New Study Validates Payer/Physician Use of AI to Cut Wasteful Spending on High-Cost, Low-Value Cancer Drugs
Healthcare AI can guide drug selection to improve effectiveness, avoid waste and drive value for payers and patients. SAN DIEGO, CA, UNITED STATES, March 28, 2022 /EINPresswire.com/ -- The Research Consortium announced the release of a new study today …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
